The Ecstasy and Related Drugs Reporting System (EDRS)

image - Edrs Logo 280 0
Tags:
Date Commenced:
01/2003
Expected Date of Completion:
Ongoing
Project Supporters:

Australian Government Department of Health

Drug Type:
Project Members: 
image - Amy Peacock 2016 Square 280
Senior Research Fellow (UNSW)
Ph +61 (2) 9385 0333
image - 1313980976 Amanda Roxburgh 010
Senior Research Officer
Ph 02 9385 0333
image - Toni Hordern Square
Research Officer
Ph +61 2 9385 0407
image - Rachel Sutherland
Research Officer
Ph 02 9385 0256
image - Michael Farrell
Director
Ph EA Jemma Sale: 02 9385 0292 / j.sale@unsw.edu.au
image - Julia Uporova
Research Officer
Ph + 61 2 9385 0161
Project Main Description: 

The Ecstasy and Related Drugs Reporting System (EDRS) is a national monitoring system for ecstasy and related drugs that is intended to identify emerging trends of local and national interest in the markets for these drugs. The EDRS is based on the Illicit Drug Reporting System (IDRS) methodology and consists of interviews with people who regularly use ecstasy and other stimulant, as well as analysis and examination of indicator data sources related to ecstasy and other related drugs. EDRS is designed to be sensitive to trends, providing data in a timely manner, rather than describing issues in extensive detail.

You can access EDRS Reports via the following links:
Drug Trends National Reports
Drug Trends Jurisdictional Reports
Drug Trends Bulletins

For news and research findings from the Drug Trends team please subscribe to the Drug Trends email newsletter.

Interested in accessing existing interview data to conduct analyses or requesting additional data be asked of the participants in the Ecstasy and Related Drugs Reporting System (EDRS)? Please contact the Drug Trends team (drugtrends@unsw.edu.au) for more information.

Project Collaborators: External: 

Professor Paul Dietze, Burnet Institute 

A/Professor Raimondo Bruno, University of Tasmania 

Professor Rosa Alati, University of Queensland 

Professor Simon Lenton, National Drug Research Institute  

Project Research Area: 
Drug Type: 
Project Status: 
Current